Validation of a model to assess long-term disease progression in Alzheimer's disease patients treated with rivastigmine

被引:0
|
作者
Hauber, B
Candrilli, S
Snyder, EH
McBurney, CR
机构
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Res Triangle Inst, Chapel Hill, NC USA
关键词
D O I
10.1016/S0197-4580(04)80457-3
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:S136 / S136
页数:1
相关论文
共 50 条
  • [31] Rivastigmine patch and massage for Alzheimer's disease patients
    Satoh, Sachiko
    Kajiwara, Mutsuko
    Kiyokawa, Emi
    Toukairin, Yoshiko
    Fujii, Masahiko
    Sasaki, Hidetada
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2013, 13 (02) : 515 - 516
  • [32] Rivastigmine in patients with Alzheimer's disease and concurrent hypertension
    Erkinjuntti, T
    Skoog, I
    Lane, R
    Andrews, C
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (10) : 791 - 796
  • [33] Evaluating improvements in rCBF in patients with Alzheimer's disease treated with rivastigmine using SPM
    Venneri, A
    Shanks, MF
    Staff, RT
    Pestell, SJ
    Forbes, KE
    Gemmell, HG
    NEUROIMAGE, 2001, 13 (06) : S1112 - S1112
  • [34] Rivastigmine: An acetylcholinesterase inhibitor for patients with Alzheimer's disease
    White, CM
    Dicks, RS
    FORMULARY, 1999, 34 (06) : 493 - +
  • [35] Long-term tacrine treatment in Alzheimer's disease
    Farre, M
    Roset, PN
    LANCET, 1996, 348 (9035): : 1181 - 1182
  • [36] Alzheimer's disease: Long-term care issues
    Kovach, CR
    ISSUES IN LAW & MEDICINE, 1996, 12 (01) : 47 - 56
  • [37] Alzheimer's disease - A long-term study with Donepezil
    Diener, HC
    PSYCHOPHARMAKOTHERAPIE, 1999, 6 (02): : 75 - 76
  • [38] Long-term treatment of Alzheimer's disease with idebenone
    Gutzmann, H
    Hadler, D
    Erzigkeit, H
    ALZHEIMER'S DISEASE: BIOLOGY, DIAGNOSIS AND THERAPEUTICS, 1997, : 687 - 705
  • [39] Long-term forgetting in preclinical Alzheimer's disease
    Reiman, Eric M.
    LANCET NEUROLOGY, 2018, 17 (02): : 104 - 105
  • [40] Long-term effects of Alzheimer's disease treatment
    Wimo, Anders
    LANCET NEUROLOGY, 2015, 14 (12): : 1145 - 1146